Back to top
more

HUTCHMED (China) Limited Sponsored ADR (HCM)

(Delayed Data from NSDQ)

$18.16 USD

18.16
185,421

-0.83 (-4.37%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $18.16 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value D Growth A Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (76 out of 252)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for HCM

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for HUTCHMED China Limited Sponsored ADR falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 886 631 1,012 435 217
Receivables 132 152 165 75 59
Notes Receivable 0 0 0 0 0
Inventories 50 57 36 20 16
Other Current Assets 28 0 0 1 25
Total Current Assets 1,097 840 1,212 531 317
Net Property & Equipment 100 76 41 24 22
Investments & Advances 48 74 76 140 99
Other Non-Current Assets 0 0 0 0 16
Deferred Charges 15 15 9 2 1
Intangibles 0 0 0 0 3
Deposits & Other Assets 15 16 22 20 1
Total Assets 1,280 1,029 1,373 724 465
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 27 0 0
Accounts Payable 36 71 41 32 24
Current Portion Long-Term Debt 31 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 3 1 16 1 2
Other Current Liabilities 329 282 228 123 84
Total Current Liabilities 403 354 312 158 113
Mortgages 0 0 0 0 0
Deferred Taxes/Income 71 3 3 6 3
Convertible Debt 0 0 0 0 0
Long-Term Debt 48 18 0 27 27
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 11 13 12 8 6
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 536 393 333 205 152
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 87 86 86 73 67
Capital Surplus 1,522 1,497 1,505 822 515
Retained Earnings -871 -971 -610 -416 -290
Other Equity 5 25 58 39 21
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 743 637 1,040 519 313
Total Liabilities & Shareholder's Equity 1,280 1,029 1,373 724 465
Total Common Equity 743 637 1,040 519 313
Shares Outstanding 174.20 172.90 172.90 133.30 133.30
Book Value Per Share 4.27 3.68 6.01 3.89 2.35

Fiscal Year End for HUTCHMED China Limited Sponsored ADR falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 886 -99,999 856 -99,999
Receivables NA 132 NA 158 NA
Notes Receivable NA 0 NA NA NA
Inventories NA 50 NA 54 NA
Other Current Assets NA 28 NA 22 NA
Total Current Assets NA 1,097 NA 1,090 NA
Net Property & Equipment NA 100 NA 97 NA
Investments & Advances NA 48 NA 38 NA
Other Non-Current Assets NA 0 NA 33 NA
Deferred Charges NA 15 NA NA NA
Intangibles NA 0 NA NA NA
Deposits & Other Assets NA 15 NA 40 NA
Total Assets NA 1,280 NA 1,298 NA
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 NA NA NA
Accounts Payable NA 36 NA 55 NA
Current Portion Long-Term Debt NA 31 NA NA NA
Current Portion Capital Leases NA 0 NA NA NA
Accrued Expenses NA 0 NA NA NA
Income Taxes Payable NA 3 NA NA NA
Other Current Liabilities NA 329 NA 286 NA
Total Current Liabilities NA 403 NA 341 NA
Mortgages NA 0 NA NA NA
Deferred Taxes/Income NA 71 NA 97 NA
Convertible Debt NA 0 NA NA NA
Long-Term Debt NA 48 NA 40 NA
Non-Current Capital Leases NA 0 NA NA NA
Other Non-Current Liabilities NA NA 19 NA
Minority Interest (Liabilities) NA 0 NA NA NA
Total Liabilities NA 536 NA 497 NA
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 NA NA NA
Common Stock (Par) NA 87 NA 87 NA
Capital Surplus NA 1,522 NA 1,506 NA
Retained Earnings NA -871 NA -803 NA
Other Equity NA 5 NA 10 NA
Treasury Stock NA 0 NA NA NA
Total Shareholder's Equity NA 743 NA 800 NA
Total Liabilities & Shareholder's Equity NA 1,280 NA 1,298 NA
Total Common Equity 0 743 0 100,799 0
Shares Outstanding 174.20 174.20 174.20 173.20 172.90
Book Value Per Share 0.00 4.27 0.00 581.98 0.00